Pulmonary alveolar lipoproteinosis. Remission after antibiotic treatment.
作者信息
Gumpert B C, Nowacki M R, Amundson D E
机构信息
Department of Critical Care Medicine, Naval Hospital, San Diego, California 92134-5000.
出版信息
West J Med. 1994 Jul;161(1):66-8.
Abstract
摘要
相似文献
1
Pulmonary alveolar lipoproteinosis. Remission after antibiotic treatment.肺泡蛋白沉积症。抗生素治疗后缓解。
West J Med. 1994 Jul;161(1):66-8.
2
Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance.
J Pediatr. 2004 Aug;145(2):268-72. doi: 10.1016/j.jpeds.2004.04.047.
3
[Response to inhaled granulocyte-macrophage colony-stimulating factor in a patient with alveolar proteinosis].[肺泡蛋白沉积症患者对吸入粒细胞巨噬细胞集落刺激因子的反应]
Arch Bronconeumol. 2009 Mar;45(3):150-2. doi: 10.1016/j.arbres.2008.02.006. Epub 2009 Feb 10.
4
[Streptococcus pneumoniae infection: cause or consequence of pulmonary alveolar proteinosis?].
Arch Bronconeumol. 2008 Nov;44(11):645-6. doi: 10.1157/13128332.
5
Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: a pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: a case report.粒细胞巨噬细胞集落刺激因子吸入疗法治疗特发性肺泡蛋白沉积症患者：一项试点研究；以及雾化粒细胞巨噬细胞集落刺激因子的长期治疗：一例病例报告。
Respirology. 2006 Jan;11 Suppl:S61-4. doi: 10.1111/j.1440-1843.2006.00811.x.
6
Inherited surfactant protein-B deficiency.遗传性表面活性蛋白B缺乏症。
Adv Pediatr. 1997;44:369-88.
7
[Case of pulmonary alveolar proteinosis with silicosis].[矽肺合并肺泡蛋白沉积症病例]
Nihon Kyobu Shikkan Gakkai Zasshi. 1983 Jun;21(6):591-5.
8
[A case of pulmonary alveolar proteinosis and lymphoma].[一例肺泡蛋白沉积症合并淋巴瘤]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Feb;29(1):120-1.
9
Successful therapy with whole-lung lavage and autologous peripheral blood stem cell transplantation for pulmonary alveolar proteinosis complicating acute myelogenous leukemia.全肺灌洗联合自体外周血干细胞移植成功治疗并发急性髓性白血病的肺泡蛋白沉积症。
Am J Hematol. 2006 Feb;81(2):107-9. doi: 10.1002/ajh.20473.
引用本文的文献
1
Autoimmune Pulmonary Alveolar Proteinosis That Improved after a COVID-19 Episode.自身免疫性肺泡蛋白沉积症在 COVID-19 发作后改善。
Intern Med. 2023 Aug 1;62(15):2237-2241. doi: 10.2169/internalmedicine.1592-23. Epub 2023 May 10.
本文引用的文献
1
Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations.
Hum Pathol. 1980 Sep;11(5 Suppl):527-35.
2
Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis).肺泡蛋白沉积症（磷脂沉积症）的临床诊断、管理及发病机制的最新进展
Chest. 1984 Apr;85(4):550-8. doi: 10.1378/chest.85.4.550.
3
Focal pulmonary alveolar proteinosis in pulmonary tuberculosis.
Arch Pathol. 1969 Mar;87(3):347-52.
4
Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review.
Mayo Clin Proc. 1987 Jun;62(6):499-518. doi: 10.1016/s0025-6196(12)65477-9.
5
Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome.两名获得性免疫缺陷综合征患者发生继发性肺泡蛋白沉积症。
Am J Med. 1986 Jun;80(6):1187-90. doi: 10.1016/0002-9343(86)90683-2.
6
Are AIDS patients at risk for pulmonary alveolar proteinosis?
Chest. 1989 Sep;96(3):641-2. doi: 10.1378/chest.96.3.641.
Zotero 插件